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Herpes Zoster Duplex Bilateralis
Sean Branch, DO, Arthur Sosis, MD and Stephen M. Purcell, DO
Lehigh Valley Health Network, Allentown, Pennsylvania

Case Presentation

Discussion

Patient: 81 year-old Italian male.
History of Present Illness: This patient was admitted for progressive
weakness and dizziness with two recent falls. He also complained of a worsening painful rash
that started two weeks prior on the right face. It was associated with swelling and blurriness
of the right eye along with numbness over the right forehead. The patient was initially
given an unknown cream by his PCP which did not seem to help. He also complained of an
asymptomatic rash on his left chest that first appeared about 1 week after the onset of the
facial rash. He denied shortness of breath, photophobia or neck stiffness.
Medical History/Surgical History: Childhood varicella, left eye cataract
S/P YAG laser posterior capsulotomy, coronary artery disease, coronary artery bypass graft,
diabetes mellitus
Medications: ASA, famotidine, enoxaparin, insulin lispro
Previous Treatments: Unknown cream prescribed by PCP
Physical Examination: Significant right periocular erythema and edema. Several
hemorrhagic vesicles and bullae on an erythematous, edematous base on the right scalp,
forehead, cheek and upper eyelid in a V1 distribution with sharp demarcation at midline. Some
shallow ulcers with exudative and hemorrhagic crusting are also present. No ear, nose or oral
lesions noted. Erythematous papules and vesicles coalescing into linear plaques on the left
chest extending to the left lateral back in the T7 dermatome. Less than 20 scattered discrete
vesicles with an erythematous base on abdomen and anterior thighs, right > left. Cranial
nerves intact. Grip strength 5/5. Hyperesthesia on right V1 distribution.
Laboratory Data: VZV direct fluorescent antibody (DFA) and viral culture: positive for
VZV, blood culture, CBC, BMP, LFT: WNL or negative

The varicella-zoster virus (VZV) is a neurotropic herpes virus (HHV-3) with worldwide distribution. In the United States 99.5%
of adults are seropositive. The primary mode of transmission is via airborne droplets although direct contact can also transmit
disease. VZV has the ability to cause two clinically distinct diseases. Primary VZV infection causes varicella (chickenpox) which is
characterized by malaise, viremia and a diffuse rash. Following infection the virus establishes lifelong latency in multiple dorsal
root, cranial nerve and autonomic ganglia. Postmortem studies have found latent VZV DNA in 94% of studied ganglia. Herpes
zoster (HZ) is caused by reactivation of latent VZV with viral replication and spread via retrograde axonal flow to the corresponding
dermatome. The mechanism for reactivation is complex and not fully understood but results from decreasing VZV-specific T-cell
mediated immunity over time. Reactivation of VZV can occur at any time but typically occurs in adults over the age of 50.
Over 1 million new HZ cases are diagnosed each year with up to 4% requiring hospitalization. Approximately 1 in 3 persons
will develop HZ during their lifetime. Declining VZV-specific host immunity as seen with advanced age, HIV infection,
immunosuppressive therapy and malignancy (most commonly leukemia and lymphoma) are the greatest risk factors for HZ.
Herpes zoster typically presents with a characteristic unilateral dermatomal eruption consisting of erythematous macules
and plaques which evolve to vesicles and pustules on an erythematous base before becoming dry and crusted after 7–10
days. A prodrome of intense pain, pruritus or tingling sensations usually precedes the onset by 2-3 days. Herpes zoster is
characteristically limited to a single unilateral dermatome. Bilateral involvement and recurrences are rare. When multiple
dermatomes are involved (multidermatomal HZ) they tend to be contiguous. The phenomenon of HZ occurring in two
noncontiguous, widely separated dermatomes is referred to as herpes zoster duplex bilateralis (HZDB) or unilateralis, depending
on whether one or both sides of the body are affected. This presentation of HZ is exceedingly rare with 23 reported cases
worldwide. The vast majority of reported cases involve advanced age or immunocompromised patients. However, HZDB does not
seem to represent a risk factor for poor prognosis. The dermatomes most frequently affected are the thoracic, trigeminal and
lumbar.
Treatment of HZDB is not standardized but is typically similar to HZ. Antiviral therapy is the mainstay. The goal of therapy is to
expedite resolution and decrease duration of zoster related pain. Intravenous therapy should be considered for severe cases,
ophthalmic or otic involvement and immunosuppressed patients. A live attenuated VZV vaccine is currently recommended for
prevention of HZ and its sequalae in adults aged ≥60 years who have no contraindications, including those with a history of HZ or
chronic medical conditions.
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Figures 1, 2 & 3: Right periocular erythema and edema. Several hemorrhagic vesicles and bullae on an erythematous edematous base on the
right scalp, forehead, cheek and upper eyelid in the V1 distribution with sharp demarcation at midline. Shallow ulcers with exudative and hemorrhagic
crusting are also present.

Figure 4: Erythematous papules and vesicles coalescing
into linear plaques on the left lateral chest extending to the
left lateral back in the T7 dermatome.

